Skip to main content

Table 3 Recurrence and progression after PUNLMP reported in the literature and in this study

From: Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth

Study No. Recur (any) (%) Recur PUNLMP (%) Progress (LG, HG, CIS) (%) Progress to LG (%) Progress to HG (%) Progress with invasion (%) Mortality (%)
[5] 112 29.5 3.6 10.7 3.6 3.6 3.6 2.7
[6] 8 33.3 NA 0 NA NA 0 0
[21] 20 25 25 0 0 0 0 NA
[7] 68 32.4 NA 0 NA NA NA 0
[8] 116 32.8 NA 2.6 NA NA NA 0.9
[9] 19 47.4 NA NA NA NA NA NA
[22] 29 NA NA 6.9 NA NA 6.9 NA
[10] 53 60 30 42 34 0 8 0
[11] 45 62.2 NA NA NA NA NA NA
[14] 12 25 NA 8.3 8.3 0 0 NA
[18] 27 51.9 51.9 0 0 0 0 0.0
[12] 85 47.1 47.1 0 0 0 0 NA
[13] 212 17.9 NA 1.9 NA NA NA 0
[15] 31 41.9 12.9 29.0 25.8 3.2 0 0
Current study 189 20.1 9 11.1 9.5 1.6 1.0 0
Range 8-212 16.7-62.2 3.6-51.9 0-42 0-34 0-3.6 0-8 0-2.7